Popular Science

News

Focus on corporate dynamics,Insight into development frontiers

China's First Estrogen Receptor 1 (ESR1) Inhibitor Indicated for Breast Cancer Obtains Marketing Authorization

China's First Estrogen Receptor 1 (ESR1) Inhibitor Indicated for Breast Cancer Obtains Marketing Authorization

On June 22, 2026, the National Medical Products Administration of China officially granted marketing approval to L...

Rare NRG1 Fusions Detected in Lung Cancer: In the Absence of Domestically Approved Therapeutics, How Can Treatment Progress Be Achieved?

Rare NRG1 Fusions Detected in Lung Cancer: In the Absence of Domestically Approved Therapeutics, How Can Treatment Progress Be Achieved?

In the current era of precision oncology, drugs targeting common driver mutations such as EGFR and AL...

PTEN Deficiency: Activation of AKT1 and the Dual Therapeutic Landscape of Capivasertib

PTEN Deficiency: Activation of AKT1 and the Dual Therapeutic Landscape of Capivasertib

The clinical significance of AKT1 lies not in the identification of a novel mutant gene, but in open...

Capivasertib is Approved for Patients with PTEN Deficiency in Prostate Cancer

Capivasertib is Approved for Patients with PTEN Deficiency in Prostate Cancer

On June 12, 2026, the U.S. Food and Drug Administration (FDA) officially approved Capivasertib (Truqap)...

A New Perspective on Endometrial Cancer in the New Era: Insights from a Review in JAMA

A New Perspective on Endometrial Cancer in the New Era: Insights from a Review in JAMA

In recent years, the incidence and mortality rates of endometrial cancer have been on a continuous up...

The Clinical - Pathological Significance of Molecular Typing of Endometrial Cancer Inspired by the Film

The Clinical - Pathological Significance of Molecular Typing of Endometrial Cancer Inspired by the Film "Dear You"

Just as in the era of precision medicine, when examining cancer, we no longer merely inquire whether...